loadpatents
name:-0.014147043228149
name:-0.017467021942139
name:-0.011408805847168
Mule; James J. Patent Filings

Mule; James J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mule; James J..The latest application filed is for "immune gene signatures in cancer".

Company Profile
1.10.14
  • Mule; James J. - Odessa FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
Grant 11,401,506 - Sarnaik , et al. August 2, 2
2022-08-02
Immune Gene Signatures in Cancer
App 20210381061 - Mule; James J. ;   et al.
2021-12-09
Immune Gene Signatures in Cancer
App 20200399706 - Mule; James J. ;   et al.
2020-12-24
Immune gene signatures in treating breast cancer
Grant 10,648,040 - Mule , et al.
2020-05-12
Immune gene signatures in urothelial carcinoma (UC)
Grant 10,583,183 - Magliocco , et al.
2020-03-10
Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
App 20200032209 - Sarnaik; Amod A. ;   et al.
2020-01-30
Immune Gene Signatures in Cancer
App 20190010556 - Mule; James J. ;   et al.
2019-01-10
Immune gene signatures in cancer
Grant 10,041,129 - Mule , et al. August 7, 2
2018-08-07
Immune Gene Signatures in Urothelial Carcinoma (UC)
App 20170175199 - MAGLIOCCO; Anthony M. ;   et al.
2017-06-22
Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
App 20170044496 - Sarnaik; Amod A. ;   et al.
2017-02-16
Immune Gene Signatures in Cancer
App 20160326599 - Mule; James J. ;   et al.
2016-11-10
Immune gene signatures in cancer
Grant 9,404,926 - Mule , et al. August 2, 2
2016-08-02
Creating bioengineered lymph nodes
Grant 9,234,175 - Mule January 12, 2
2016-01-12
Methods And Apparatuses Using Molecular Fingerprints To Provide Targeted Therapeutic Strategies
App 20150154368 - Lancaster; Johnathan M. ;   et al.
2015-06-04
Enhanced dendritic cells for cancer immunotherapy
Grant 8,597,946 - Mule , et al. December 3, 2
2013-12-03
Chemokine Gene-modified Cells For Cancer Immunotherapy
App 20130251752 - Antonia; Scott J. ;   et al.
2013-09-26
Immune Gene Signatures in Cancer
App 20130034540 - Mule; James J. ;   et al.
2013-02-07
Creating Bioengineered Lymph Nodes
App 20120244181 - Mule; James J.
2012-09-27
Chemokine Gene-modified Cells For Cancer Immunotherapy
App 20110059137 - Antonia; Scott Joseph ;   et al.
2011-03-10
Enhanced Dendritic Cells For Cancer Immunotherapy
App 20110059054 - Mule; James J. ;   et al.
2011-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed